@article{ref1,
title="Venlafaxine and serious withdrawal symptoms: warning to drivers",
journal="Medscape general medicine",
year="2005",
author="Campagne, Daniel M.",
volume="7",
number="3",
pages="22-22",
abstract="Venlafaxine is a widely used serotonin- and norepinephrine-reuptake inhibitor-type antidepressant that causes serious adverse effects in at least 5% of cases. Serious withdrawal symptoms may occur within hours of cessation or reduction of the usual dosage and may affect motor and coordination skills to such a degree that patients should be explicitly urged either to adhere to a strict medication routine or not to drive a car. Recent clinical evidence about withdrawal symptoms is presented that may indicate incidents in noradrenergic activity irrespective of dosage.<p /> <p>Language: en</p>",
language="en",
issn="1531-0132",
doi="",
url="http://dx.doi.org/"
}